Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colitis, Ulcerative | 3 | 2022 | 217 | 0.410 |
Why?
|
| Crohn Disease | 3 | 2022 | 291 | 0.400 |
Why?
|
| Enterobacteriaceae | 2 | 2020 | 41 | 0.300 |
Why?
|
| Escherichia coli | 3 | 2020 | 995 | 0.240 |
Why?
|
| Enterobacteriaceae Infections | 3 | 2020 | 56 | 0.230 |
Why?
|
| Mitochondrial Myopathies | 1 | 2023 | 28 | 0.200 |
Why?
|
| United Kingdom | 5 | 2021 | 235 | 0.200 |
Why?
|
| Carbapenems | 2 | 2020 | 43 | 0.190 |
Why?
|
| Plasmids | 2 | 2020 | 459 | 0.180 |
Why?
|
| beta-Lactamases | 2 | 2020 | 208 | 0.170 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2020 | 6 | 0.170 |
Why?
|
| Carbapenem-Resistant Enterobacteriaceae | 1 | 2019 | 4 | 0.160 |
Why?
|
| Molecular Epidemiology | 1 | 2020 | 146 | 0.160 |
Why?
|
| Virus Diseases | 1 | 2022 | 289 | 0.150 |
Why?
|
| Bacterial Proteins | 4 | 2020 | 930 | 0.150 |
Why?
|
| Acinetobacter baumannii | 1 | 2019 | 47 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2022 | 326 | 0.140 |
Why?
|
| Colistin | 1 | 2018 | 32 | 0.140 |
Why?
|
| Carrier State | 1 | 2018 | 77 | 0.140 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2020 | 382 | 0.130 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 149 | 0.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 664 | 0.120 |
Why?
|
| Quality of Life | 1 | 2023 | 2157 | 0.100 |
Why?
|
| Hospitalization | 1 | 2020 | 1898 | 0.090 |
Why?
|
| Streptolysins | 2 | 2001 | 9 | 0.090 |
Why?
|
| Biomarkers | 1 | 2020 | 3404 | 0.080 |
Why?
|
| Pneumonia, Pneumococcal | 2 | 2001 | 87 | 0.080 |
Why?
|
| Pneumococcal Infections | 2 | 2001 | 277 | 0.070 |
Why?
|
| Whole Genome Sequencing | 2 | 2020 | 327 | 0.070 |
Why?
|
| Bacteremia | 2 | 2001 | 428 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2020 | 827 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 4 | 2020 | 2554 | 0.060 |
Why?
|
| Humans | 15 | 2023 | 131924 | 0.060 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2023 | 11 | 0.050 |
Why?
|
| Middle Aged | 7 | 2023 | 28943 | 0.050 |
Why?
|
| Fatigue | 1 | 2023 | 202 | 0.050 |
Why?
|
| Point-of-Care Testing | 1 | 2022 | 33 | 0.050 |
Why?
|
| Male | 8 | 2023 | 64870 | 0.040 |
Why?
|
| Prevalence | 2 | 2019 | 2658 | 0.040 |
Why?
|
| Dexamethasone | 1 | 2023 | 274 | 0.040 |
Why?
|
| State Medicine | 1 | 2021 | 21 | 0.040 |
Why?
|
| Antigen-Antibody Complex | 1 | 2001 | 64 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2001 | 806 | 0.040 |
Why?
|
| Triage | 1 | 2022 | 149 | 0.040 |
Why?
|
| Female | 8 | 2023 | 70584 | 0.040 |
Why?
|
| Streptococcus pneumoniae | 2 | 2001 | 381 | 0.040 |
Why?
|
| Clavulanic Acid | 1 | 2020 | 7 | 0.040 |
Why?
|
| Smokers | 1 | 2020 | 44 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2021 | 5163 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 305 | 0.040 |
Why?
|
| Respiratory Tract Diseases | 1 | 2020 | 80 | 0.040 |
Why?
|
| Conjunctivitis, Bacterial | 1 | 1999 | 5 | 0.040 |
Why?
|
| Laos | 1 | 2019 | 6 | 0.040 |
Why?
|
| Klebsiella Infections | 1 | 2020 | 60 | 0.040 |
Why?
|
| Metabolome | 1 | 2022 | 325 | 0.040 |
Why?
|
| Public Health Surveillance | 1 | 2019 | 45 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2023 | 1656 | 0.040 |
Why?
|
| Acinetobacter Infections | 1 | 2019 | 36 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2020 | 213 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2020 | 430 | 0.040 |
Why?
|
| Antibodies, Bacterial | 1 | 2001 | 406 | 0.040 |
Why?
|
| Metabolomics | 1 | 2022 | 480 | 0.040 |
Why?
|
| DNA, Bacterial | 1 | 2020 | 494 | 0.040 |
Why?
|
| Escherichia coli Infections | 1 | 2019 | 192 | 0.030 |
Why?
|
| Hospitals | 1 | 2020 | 438 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 504 | 0.030 |
Why?
|
| Klebsiella pneumoniae | 1 | 2018 | 85 | 0.030 |
Why?
|
| China | 1 | 2018 | 290 | 0.030 |
Why?
|
| Cephalosporins | 1 | 2018 | 139 | 0.030 |
Why?
|
| Child | 4 | 2022 | 25761 | 0.030 |
Why?
|
| Antiviral Agents | 1 | 2022 | 822 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2023 | 12991 | 0.030 |
Why?
|
| Health Personnel | 1 | 2020 | 543 | 0.030 |
Why?
|
| Escherichia coli Proteins | 1 | 2018 | 316 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2020 | 14732 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 1228 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1519 | 0.030 |
Why?
|
| Length of Stay | 1 | 2020 | 1380 | 0.030 |
Why?
|
| Prognosis | 2 | 2021 | 5007 | 0.030 |
Why?
|
| Feces | 1 | 2018 | 755 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 1169 | 0.030 |
Why?
|
| Aged | 3 | 2021 | 21385 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2020 | 625 | 0.030 |
Why?
|
| Electronic Health Records | 1 | 2021 | 800 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1183 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2020 | 6569 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 7097 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 20535 | 0.020 |
Why?
|
| Phenotype | 1 | 2020 | 4526 | 0.020 |
Why?
|
| Adult | 4 | 2019 | 31536 | 0.020 |
Why?
|
| Infant | 2 | 2019 | 13047 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17374 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2001 | 107 | 0.010 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2001 | 67 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2001 | 201 | 0.010 |
Why?
|
| Virulence | 1 | 2001 | 279 | 0.010 |
Why?
|
| Serotyping | 1 | 1999 | 178 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2000 | 153 | 0.010 |
Why?
|
| DNA Fingerprinting | 1 | 1999 | 109 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2001 | 822 | 0.010 |
Why?
|
| Eye | 1 | 1999 | 235 | 0.010 |
Why?
|
| Phylogeny | 1 | 1999 | 763 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1999 | 1547 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 2140 | 0.010 |
Why?
|
| Time Factors | 1 | 2001 | 6440 | 0.010 |
Why?
|
| Risk Factors | 1 | 2000 | 10933 | 0.000 |
Why?
|
| Mice | 1 | 2001 | 18460 | 0.000 |
Why?
|
| Animals | 1 | 2001 | 34781 | 0.000 |
Why?
|